Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

DES Home | For Consumers | For Health Care Providers
For DES Update Partners | Contact Us
DES Update: Consumers

Notice! Content may be out of date
The following content is no longer maintained and may be out of date. Persons with disabilities having difficulty accessing the information on this page may contact cdcinfo@cdc.gov for assistance. Please view the Updated Bibliographies on the Updated Bibliographies page for updated information on this topic.



 Consumers Home
 About DES
 DES Research
 Understanding DES Research
 Recent DES Research
 What You Can Do
 DES Teleconferences
 Additional Resources
 Interactive DES Self-Assessment Guide
 Women Prescribed DES While Pregnant
 DES Daughters
 DES Sons
 DES Third Generation

Email this page
Order DES materials
Download DES materials
Image of a woman using a microscope  DES Research
Consumers Home > DES Research > Recent DES Research > Cancer Risk in Women Exposed to Diethylstibestrol in Utero
Cancer Risk in Women Exposed to Diethylstibestrol in Utero (Hatch et al., 1998)

In this study, the researchers wanted to learn whether women exposed to DES before birth (in the womb), known as DES Daughters, were more likely to develop cancer than unexposed women. Cancer rates of DES Daughters were also compared with cancer rates among women in the general population whose DES exposure status was unknown. At the time of this study, researchers accepted that DES exposure before birth increased a woman's risk of developing clear cell adenocarcinoma (CCA) of the vagina and cervix. However, researchers were not certain whether the risk for other types of cancer also increased.

Over a 16-year period, the researchers compared the medical histories of 3,650 DES Daughters with those of 1,202 unexposed women. The researchers then compared cancer rates from the two study groups to cancer rates for women in the general population whose DES exposure status was not known.

The researchers found that for DES Daughters, the rate for all types of cancer (other than CCA) was similar to the rates for unexposed women and women in the general population. In addition, DES Daughters were 40 times more likely than women in the general population to develop CCA.

Although this study was one of the largest of its kind, the study had some limitations. For example, the average age of DES Daughters who participated was 24 at the start of the study and 38 at last follow-up. The researchers suggested continued study of these DES Daughters for any increased cancer risks during menopausal years.

Another limitation of this study concerned breast cancer. Many studies have demonstrated that women exposed to estrogen in high doses or over a long period of time have an increased risk for breast cancer. However, breast cancer is most likely to occur in older women. Thus, the women in this study will have to be monitored over the next several decades to determine whether DES Daughters develop breast cancer at higher rates than do unexposed women.

Citation: Hatch EE, Palmer JR, Titus-Ernstoff L, Noller KL, Kaufman RH, et al. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998;280:630-4.

   

Recent DES Research

 Overview
WOMEN PRESCRIBED DES WHILE PREGNANT
 Long-Term Cancer Risk in Women Given DES During Pregnancy
DES DAUGHTERS
 Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol
 Cancer Risk in Women Exposed to DES in Utero
 Continued Follow-Up of Pregnancy Outcomes in DES-Exposed Offspring
 Infertility Among Women Exposed Prenatally to DES
 Incidence of Squamous Neoplasia of the Cervix and Vagina
 Risk of Breast Cancer in Women Exposed to DES in Utero
DES SONS
 Psychosexual Characteristics of Men and Women Exposed Prenatally to Diethylstilbestrol
 Cancer Risk in Men Exposed in Utero to DES
THIRD GENERATION (Offspring of DES Daughters & Sons)
 Findings in Female Offspring of Women Exposed in Utero to DES
 Hypospadias in Sons of Women Exposed to DES in Utero


Back to Top

Contact Us | Site Map | Privacy Policy | Disclaimer | FOIA | Accessibility

CDC Home | Search | Health Topics A-Z



United States Department of Health and Human Services
Centers for Disease Control and Prevention